| Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1272 | 2013 |
| Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014 | 1088 | 2014 |
| Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer FJ Couch, SN Hart, P Sharma, AE Toland, X Wang, P Miron, JE Olson, ... Journal of clinical oncology 33 (4), 304-311, 2015 | 735 | 2015 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 557 | 2015 |
| Hereditary breast cancer: the era of new susceptibility genes P Apostolou, F Fostira BioMed research international 2013 (1), 747318, 2013 | 486 | 2013 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 413 | 2017 |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674-685, 2020 | 368 | 2020 |
| A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer CA Haiman, GK Chen, CM Vachon, F Canzian, A Dunning, RC Millikan, ... Nature genetics 43 (12), 1210-1214, 2011 | 351 | 2011 |
| Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020 | 336 | 2020 |
| Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ... JNCI: Journal of the National Cancer Institute 109 (7), djw302, 2017 | 326 | 2017 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 310 | 2015 |
| Triple-negative breast cancer risk genes identified by multigene hereditary cancer panel testing H Shimelis, H LaDuca, C Hu, SN Hart, J Na, A Thomas, M Akinhanmi, ... JNCI: Journal of the National Cancer Institute 110 (8), 855-862, 2018 | 308 | 2018 |
| Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer KS Purrington, S Slager, D Eccles, D Yannoukakos, PA Fasching, P Miron, ... Carcinogenesis 35 (5), 1012-1019, 2014 | 212 | 2014 |
| The role of phosphoinositide 3-kinase C2α in insulin signaling M Falasca, WE Hughes, V Dominguez, G Sala, F Fostira, MQ Fang, ... Journal of Biological Chemistry 282 (38), 28226-28236, 2007 | 207 | 2007 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 190 | 2017 |
| Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants S Li, V Silvestri, G Leslie, TR Rebbeck, SL Neuhausen, JL Hopper, ... Journal of Clinical Oncology 40 (14), 1529-1541, 2022 | 160 | 2022 |
| Common breast cancer susceptibility loci are associated with triple-negative breast cancer KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick, C Olswold, ... Cancer research 71 (19), 6240-6249, 2011 | 152 | 2011 |
| Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent Y Guo, S Warren Andersen, XO Shu, K Michailidou, MK Bolla, Q Wang, ... PLoS medicine 13 (8), e1002105, 2016 | 148 | 2016 |
| Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1 KB Meyer, M O’Reilly, K Michailidou, S Carlebur, SL Edwards, JD French, ... The American Journal of Human Genetics 93 (6), 1046-1060, 2013 | 142 | 2013 |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ... Journal of medical genetics 53 (5), 298-309, 2016 | 139 | 2016 |
